Fierce Biotech White Logo Fierce Biotech White Logo

Accelerating Clinical Trials and Sponsored Testing Programs Using Telegenetics

Available on-demand
60 minutes

Biopharmaceutical organizations continue to pursue the dual goals of creating more effective and efficient drug development processes while also ensuring commercial success and R&D return on investment (ROI) post commercial launch.  By incorporating telegenetics across their programs, biopharma companies can better position themselves to achieve both.  

Attendees of this educational session will come away with a deeper understanding of: 

  • How genetic counseling and genetic services workflows can help biopharma organizations more effectively identify patients that qualify for their clinical trials and/or commercial therapeutics
  • How telegenetics can be used to stimulate increased patient participation in trials or sponsored testing and better engage providers that refer patients or prescribe therapeutics
  • The industry best-practices that should be considered when incorporating genetic services into biopharma programs.
  • The value of customized genetic services workflows in optimizing clinical trial/sponsored testing program ROI. 



Molly McGinniss

Molly is a board-certified genetic counselor with extensive clinical and commercial expertise. She joined Genome Medical from Illumina, where she held market development roles focused on expansion of sequencing applications into emerging clinical markets through evidence generation and strategic partnerships. Molly began her career as a clinical genetic counselor providing prenatal, pediatric and adult genetic counseling services.She currently serves as the President of the Accreditation Council for Genetic Counseling (ACGC), having served on the board since 2018 and has held additional leadership roles for the National Society of Genetic Counselors (NSGC).


Michelle Hearn

Michelle is a board-certified genetic counselor with over 17 years of experience providing direct patient care in clinic-based and telehealth settings across multiple specialities including reproductive, cancer, and general genetics. She also worked extensively with genetic counseling masters degree programs to provide clinical supervision, including as a clinical instructor (affiliated) in the Division of Genetics at Stanford University School of Medicine. Michelle is currently a Clinical Science Liaison at Genome Medical where she works to optimize provision of genetic counseling services through evidence based recommendations, thought leadership and scalable solutions in partnership with health systems, laboratories, advocacy groups and biopharmaceutical companies.

Register here to watch on-demand!

60 minutes